Plenary Sessions and Speakers
Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs
- Chair: Allan Dietz, PhD, Mayo Clinic
- Speakers:
- Allan Dietz, PhD, Mayo Clinic
- Gil Van Bokkelen, PhD, Athersys
- Etienne Sokal, MD, PhD, Promethera, Universite Catholique de Louvain
Medicine
- Chair: William Murphy, PhD, UW-Madison
- Speakers:
- William Murphy, PhD, UW-Madison
- Timothy Kamp, MD, PhD, UW-Madison
- Mervin Yoder, MA, MD, Indiana University School of Medicine
iPSC and Pluripotent Stem Cells – True Replacement Cell Therapies
- Chair: Robert Deans, PhD, BlueRock Therapeutics
- Speakers:
- Dan Kaufman, MD, PhD, University of California San Diego
- Stephanie Protze, PhD, University of Toronto
- Robert Deans, PhD, BlueRock Therapeutic
Redirecting Immune Cells – T and NK Cells Aside from Canonical CARS
- Chair: Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute
- Speakers:
- Denis-Claude Roy, MD, Hôpital Maisonneuve-Rosemont
- Sumithira Vasu, MBBS, Ohio State University
- Lisa Butterfield, PhD, PICI, UCSF
Concurrent Sessions and Speakers
Workshops
MSC therapy; Rationalism vs. Empiricism; how much must we know to test therapies in patients; a Live Debate
- Moderator: Allan Dietz, PhD, Mayo Clinic, USA
- Speakers:
- Jacques Galipeau, MD, University of Wisconsin-Madison, USA
- William Faubion, MD, Mayo Clinic, USA
Virus Specific T Cells – Meet the Experts
- Chair: Lynn O’Donnell
- Speakers:
- Catherine Bollard, MBChB, MD, Children’s National Medical Center, USA
- John Barrett, MD, George Washington University Hospital, USA
- Michael Grimley, MD, Cincinnati Children’s Hospital Medical Center, USA
Engineering to Control Cell Environment during Expansion
- Chair: Erika Trauzzi, Berkeley Lights Inc., USA
- Speakers:
- James Lim, PhD, Xcell Biosciences Inc., USA
- Peter Beemiller, Berkeley Lights Inc., USA
- Angelo Cardoso, MD, PhD, City of Hope, USA
CAR-T Racing: Amateurs & Rookies Looking to Contribute
- Chair: Patrick Hanley, PhD, Children’s National Health System, USA
- Speakers:
- Lizette Caballero, BS, MT(ASCP), UCSF Blood and Marrow Transplant Lab, USA
- Paul Eldridge, PhD, UNC Lineberger Comprehensive Cancer Center, USA
- Hema Dave, MD, MPH, Children’s National Medical Center, USA
CAR-T Racing: The Pro Circuit + Future Prospects
- Chair: Bruce Levine, PhD, University of Pennsylvania, USA
- Speakers:
- Rebecca Gardner, MD, Seattle Children’s Hospital, USA
- Krishanu Saha, PhD, University of Wisconsin-Madison, USA
- Saar Gill, MD, PhD, Perelman School of Medicine, University of Pennsylvania, USA
ISCT-NAVRMA Joint Session: Veterinary medicine in developing cell-based therapies and bioengineering approach for human clinical use
- Co-Chairs: Daniel Weiss, MD, PhD, University of Vermont, USA and Tracey Webb, DVM, PhD, Colorado State University, USA
- Speakers:
- Andrew Hoffman, DVM, DVSc, DACVIM, University of Pennsylvania School of Veterinary Medicine, USA
- Kyla Ortved, DVM, PhD, University of Pennsylvania School of Veterinary Medicine, USA
- Aimee Colbath, DVM, Michigan State University, USA
- Dori Borjesson, BA, DVM, MPVM, PhD, UC Davis School of Veterinary Medicine, USA
ISCT PTF Session: Regulatory Aspects of Unproven Cell Therapies in North America
- Chair: Laertis Ikonomou, PhD, Boston University, USA
- Speakers:
- Peter Marks, MD, PhD, Center for Biologics Evaluation and Research, FDA, USA
- Lynne Boxer, DVM, Office of New Animal Drug Evaluation, Center for Veterinary Medicine, FDA, USA
- Ajay Kuriyan, MD, MS, Department of Ophthalmology, University of Rochester Medical Center, USA
- Kristin Matthews, PhD, Rice University’s Baker Institute for Public Policy, USA
Gene Replacement Therapy Using Adult Stem Cells
- Chair: Mitchell Cairo, MD, New York Medical College, USA
- Speakers:
- Mitchell Cairo, MD, New York Medical College, USA
- Jeffrey Medin, PhD, Medical College of Wisconsin, USA
- Paul Orchard, MD, University of Minnesota, USA
Optimizing Clinical Trials in Cellular Therapy
- Chair: Denis-Claude Roy, MD, FRCPC, Hopital Maisonneuve-Rosemont, Canada
- Speakers:
- Lauralyn McIntyre, MD, MHSc, FRCPC, Ottawa Hospital Research Institute, Canada
- Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute, USA
- Steven Devine, MD, CIBMTR, USA
Regulatory Updates – What You Need to Know When Filing Novel IND’s
- Chair: Olive Sturtevant, MHP, MT(ASCP)SBB, Dana-Farber CMCF, USA
- Speakers:
- Jessica Chery, FDA, USA
- Amanda Mack, PhD, FUJIFILM Corporation, USA
- Whitney Gladney, PhD, University of Pennsylvania Perelman School of Medicine, USA
Quality & Operations Track
Strategies for Instituting Materials Management Program for Cell and Gene Therapy Products
- Chair: Aisha Khan, MS, MBA, University of Miami, USA
- Speakers:
- Robert Lindblad, MD, EMMES, USA
- Yong Fan, MD, A2Z Reg Solutions, USA
- Lynn O’Donnell, PhD, Ohio State University, James Cancer Hospital Columbus, USA
Synchronizing CMC Preparation for Commercial Approval with Regulatory Accelerators
- Chair: Yong Fan, MD, A2Z Reg Solutions, USA
- Speakers:
- Mo Heidaran, PhD, PAREXEL, USA
- Marianna Sabatino, MD, Arcellx, USA
Media Fills
- Chair: Rosemarie Bell, B.App.Sc Micro/Biochem MASM, QIMR Berghofer Medical Research Institute/Q-Gen Cell Therapeutics, Australia
- Speaker:
- Adrian Gee, PhD, Baylor College of Medicine, USA
- Aisha Khan, MS, MBA, University of Miami, USA
Managing Growth in the Lab
- Chair: Lynn O’Donnell, PhD, Ohio State University, James Cancer Hospital Columbus, USA
Stability
- Chair: Karl Stasko, BSc, MPH, Dana Farber Cancer Institute, USA
- Speakers:
- Rosemarie Bell, B.App.Sc Micro/Biochem MASM, QIMR Berghofer Medical Research Institute/Q-Gen Cell Therapeutics, Australia
- Jackie Damen, PhD, Senior Scientific Advisor, Hematopoiesis, Canada
- Karl Stasko, BSc, MPH, Dana Farber Cancer Institute, USA
Currently Clinical Development Regulatory Guidance – Context and Implications
- Chair: Kurt Gunter, MD, Cell Medica Inc, USA
- Speakers:
- Peiman Hematti, MD, University of Wisconsin-Madison School of Medicine and Public Health, USA
- Cynthia Molina, Triumvira, USA
ISCT-ASFA Joint Session: Current Concepts in Cell Collections: HPCs, CAR-T & Regulatory Oversight
- Co-Chairs: Joseph Schwartz and Lizette Caballero
- Speakers:
- Donald Siegel, MD, PhD, Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, USA
- Anand Padmanabhan, MD, PhD, Blood Center of Wisconsin, USA
- Yvette Tanhehco, PhD, MD MS, Columbia University Irving Medical Center, USA
Real World Evidence
- Chair: Jiwen Zhang, PhD, PassageBio, USA
- Speakers:
- Adnan Jaigirdar, MD, Medical Officer, Oncology Branch; Division of Clinical Evaluation, Pharmacology and Toxicology; OTAT, CBER, FDA, USA
- Leanne Larson, MHA, Parexel International USA
Advanced Practice Professionals Track
Management of CRS toxicity or other reactions related to CAR therapy
- Chair: Valkal Bhatt, PharmD, BCOP, BCPS, Memorial Sloan Kettering Cancer Center, USA
- Speakers:
- Christina Bachmeier, PharmD, BCOP, Moffitt Cancer Center, USA
- Rebecca Gonzalez, PharmD, BCOP, Moffitt Cancer Center, USA
- Marian Dam, DNP, APRN, Moffitt Cancer Center, USA
Responsibilities of the Investigator and the Lab in the investigation, communication and reporting of Adverse Events
- Chair: Valkal Bhatt, PharmD, BCOP, BCPS, Memorial Sloan Kettering Cancer Center, USA
- Speakers:
- Julia Thebiay, IMPACT, Mayo Clinic Rochester, USA
- Ashwani Khurana, PhD, Mayo Clinic Rochester, USA